NIH-funded research Career grant

Optimizing stem cell transplants to treat non-malignant blood diseases

Official title: Optimizing hematopoietic stem cell transplantation to treat non-malignant disease

Funded at Washington University · NIH-11392266 · Data updated 2026-11-12

A researcher is pursuing a five-year plan to improve stem cell transplantation strategies for non-cancer blood illnesses, with a focus on safer conditioning, better stem cell collection, and gene editing.

More Hematopoietic Stem Cell Transplantation research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 17, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$169,156
NIH project number5K08HL168155-03
Project IDNIH-11392266 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with non-malignant hematologic diseases (e.g., sickle cell disease) who are or may be candidates for hematopoietic stem cell transplantation.

Less likely to help

Patients not eligible for transplantation or those not affected by non-malignant hematologic diseases may not benefit.

What this research studies

This program supports the physician-scientist in building independent work at Washington University, aiming to advance allogeneic and autologous hematopoietic stem cell transplantation for non-malignant diseases like sickle cell disease. The plan includes refining conditioning regimens, improving stem cell mobilization, and exploring therapeutic gene editing to enable safer transplants. Patients could benefit from more effective, safer transplant options and potential new therapies that reduce complications. The project builds on prior work with antibody-drug conjugates and cellular immunotherapy to push translational research toward clinical applications.

Why it matters

Potential benefit: If successful, patients with non-malignant hematologic diseases may access safer, more effective stem cell transplantation approaches.

How similar studies have gone: Earlier work shows promise for targeted therapies and conjugates; this grant aims to translate such approaches into safer transplant strategies.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Persaud, Stephen Phillip — Washington University
  • Study coordinator: Persaud, Stephen Phillip

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.